Using Copeptin to Differentiate Between Diabetes Insipidus and Primary Polydipsia
Baseline copeptin >21.4 pmol/L without any stimulation immediately diagnoses nephrogenic diabetes insipidus, while stimulated copeptin levels after hypertonic saline infusion or arginine/glucagon administration differentiate central diabetes insipidus from primary polydipsia using a cutoff of 4.9 pmol/L. 1, 2
Baseline Copeptin Measurement (No Stimulation Required)
For nephrogenic diabetes insipidus, measure baseline copeptin without any prior fluid deprivation or stimulation test:
- Copeptin >21.4 pmol/L = Nephrogenic DI (kidneys not responding to elevated vasopressin) 1, 3
- This threshold has been validated across multiple studies and unequivocally identifies nephrogenic DI 2, 4, 5
- No stimulation test needed when baseline copeptin exceeds this threshold 1, 6
Critical pitfall: A baseline copeptin <21.4 pmol/L does NOT rule out diabetes insipidus—it simply means you need stimulation testing to differentiate central DI from primary polydipsia 1, 3
Stimulated Copeptin Testing (For Central DI vs Primary Polydipsia)
When baseline copeptin is <21.4 pmol/L, you must perform osmotic or pharmacologic stimulation to differentiate central DI from primary polydipsia:
Hypertonic Saline Infusion Test (Gold Standard)
This is the most validated approach with superior diagnostic accuracy compared to water deprivation testing:
- Administer hypertonic saline infusion to raise serum sodium 2, 4, 5
- Copeptin <4.9 pmol/L after stimulation = Central DI 1, 2, 4, 5
- Copeptin ≥4.9 pmol/L after stimulation = Primary Polydipsia 2, 4, 5
- This cutoff has sensitivity and specificity >94% 6
Mandatory safety requirement: Monitor serum sodium every 30 minutes during the test to prevent dangerous hypernatremia 4, 5
Common side effects: Hypertonic saline frequently causes discomfort and side effects, which is why alternative stimulation methods are being studied 4
Alternative Stimulation Tests (Emerging Options)
Arginine infusion:
- Stimulates copeptin through non-osmotic mechanisms 4
- Better tolerated than hypertonic saline with fewer side effects 4
- Uses same 4.9 pmol/L cutoff for interpretation 4
Glucagon injection (1 mg subcutaneous):
- Stimulates the neurohypophysis and copeptin release 7
- Copeptin <4.6 pmol/L = Diabetes Insipidus (sensitivity 100%, specificity 90%) 7
- Copeptin ≥4.6 pmol/L = Primary Polydipsia 7
- Safer and simpler than hypertonic saline, though head-to-head comparisons are still needed 7, 4
Diagnostic Algorithm Summary
Step 1: Measure baseline copeptin without any stimulation or fluid deprivation 1, 2
Step 2: Interpret baseline result:
Step 3: Perform stimulation test (hypertonic saline, arginine, or glucagon) 2, 7, 4
Step 4: Interpret stimulated copeptin:
- If <4.9 pmol/L (or <4.6 pmol/L for glucagon) → Central DI 2, 7, 4, 5
- If ≥4.9 pmol/L (or ≥4.6 pmol/L for glucagon) → Primary Polydipsia 2, 7, 4, 5
Key Advantages Over Water Deprivation Testing
Copeptin-based testing is superior to the traditional water deprivation test:
- Higher diagnostic accuracy (>94% sensitivity and specificity vs. limited accuracy with water deprivation) 2, 4, 5, 6
- Shorter test duration (hours vs. 17 hours for water deprivation) 2, 4
- Less cumbersome for patients 2, 4
- Direct measurement of the vasopressin system rather than indirect assessment 2, 5
Important caveat: The water deprivation test followed by desmopressin administration remains an alternative when copeptin testing is unavailable, though it has inferior diagnostic performance 1, 2
Confirming the Diagnosis Before Testing
Before measuring copeptin, confirm the patient actually has polyuria-polydipsia syndrome: